T
Thomas Zeller
Researcher at University of Freiburg
Publications - 364
Citations - 23647
Thomas Zeller is an academic researcher from University of Freiburg. The author has contributed to research in topics: Angioplasty & Restenosis. The author has an hindex of 65, co-authored 321 publications receiving 20028 citations.
Papers
More filters
Journal ArticleDOI
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial
Murray D. Esler,Henry Krum,Paul A. Sobotka,Markus P. Schlaich,Roland E. Schmieder,Michael Böhm,Felix Mahfoud,Horst Sievert,Nina Wunderlich,Lars Christian Rump,Oliver Vonend,Michael Uder,Mel Lobo,Mark J. Caulfield,Andrejs Erglis,Michel Azizi,Marc Sapoval,S. Thambar,Alexandre Persu,Jean Renkin,Heribert Schunkert,Joachim Weil,Uta C. Hoppe,Tony Walton,Dierk Scheinert,Thomas Binder,Andrzej Januszewicz,Adam Witkowski,Luis M. Ruilope,Robert Whitbourn,Heike Bruck,Mark Downes,Thomas F. Lüscher,Alan G. Jardine,Mark Webster,Thomas Zeller,Jerzy Sadowski,Krzysztof Bartus,Craig A. Straley,Neil C. Barman,David P. Lee,Ronald M. Witteles,Vivek Bhalla,Joseph M. Massaro +43 more
TL;DR: Catheter-based renal denervation can safely be used to substantially reduce blood pressure in treatment-resistant hypertensive patients and should be continued, according to the authors.
Journal ArticleDOI
ESC Guidelines on the Diagnosis and Treatment of Peripheral Artery Diseases
Michel Tendera,Victor Aboyans,Marie-Louise Bartelink,Iris Baumgartner,Denis Clement,Jean-Philippe Collet,Alberto Cremonesi,Marco De Carlo,Raimund Erbel,F. Gerry R. Fowkes,Magda Heras,Serge Kownator,Erich Minar,Jan Östergren,Don Poldermans,Vincent Riambau,Marco Roffi,Joachim Röther,Horst Sievert,Marc R.H.M. van Sambeek,Thomas Zeller +20 more
TL;DR: Endorsed by: the European Stroke Organisation (ESO) Authors/Task Force Members: Michal Tendera (Chairperson) (Poland), Victor Aboyans (Co-Chair person) (France), Marie-Louise Bartelink (The Netherlands), Iris Baumgartner (Switzerland).
Journal ArticleDOI
Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg.
Gunnar Tepe,Thomas Zeller,Thomas Albrecht,S. Heller,Uwe Schwarzwälder,Jean-Paul Beregi,M.D. Claus D. Claussen,A. Oldenburg,Bruno Scheller,Ulrich Speck +9 more
TL;DR: Use of paclitaxel-coated angioplasty balloons during percutaneous treatment of femoropopliteal disease is associated with significant reductions in late lumen loss and target-lesion revascularization and no significant benefit is seen with the use of a paclitxel-containing contrast medium.
Journal ArticleDOI
Medial vascular calcification revisited: review and perspectives
Peter Lanzer,Manfred Boehm,Victor Sorribas,Marc Thiriet,Jan Janzen,Thomas Zeller,Cynthia St. Hilaire,Catherine M. Shanahan +7 more
TL;DR: The current state of knowledge about the pathology, molecular biology, and nosology of VCm is reviewed, potential mechanisms responsible for poor prognosis are expanded on, and some of the directions for future research in this area are exposed.
Journal ArticleDOI
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
Raymond R. Townsend,Felix Mahfoud,Felix Mahfoud,David E. Kandzari,Kazuomi Kario,Stuart J. Pocock,Michael A. Weber,Sebastian Ewen,Konstantinos Tsioufis,Dimitrios Tousoulis,Andrew S.P. Sharp,A. Watkinson,Roland E. Schmieder,Axel Schmid,James W. Choi,Cara East,Anthony Walton,Ingrid Hopper,Debbie L. Cohen,Robert L. Wilensky,David P. Lee,Adrian Ma,Chandan Devireddy,Janice P. Lea,Philipp Lurz,Karl Fengler,Justin E. Davies,Neil Chapman,Sidney Cohen,Vanessa DeBruin,Martin Fahy,Denise E Jones,Martin T. Rothman,Michael Böhm,Jiro Aoki,Bryan Batson,George Dangas,Shukri David,David E. Kandzari,Manesh R. Patel,Kiritkumar Patel,Jasvindar Singh,Thomas Weber,Joachim Weil,Thomas Zeller,Khaled M. Ziada,Kengo Tanabe,Robert Wilkins,Johanna Contreras,Susan Steigerwalt,Denise Reedus,Satoshi Hoshide,Laura P. Svetkey,Anjani Rao,Angela L. Brown,Markus Suppan,Tolga Agdirlioglu,Elias Noory,Craig Chasen +58 more
TL;DR: Results from SPYRAL HTN-OFF MED provide biological proof of principle for the blood-pressure-lowering efficacy of renal denervation in the absence of antihypertensive medications.